glp 1 glp 2 dual agonist Main physiological actions of the GIP and GLP-1 Evaluation of biased agonism mediated

Angarita GA, Matuskey D, Pittman B, et al

Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, et al

2024;109(3):e126779

Now a newer class of medications used to treat type 2 diabetes has gained attention because of their impressive weight-loss results in many cases, 10% to 20% of a person's body weight

By 2030, it is projected that diabetes will affect approximately 439 million people worldwide, with developing countries experiencing the highest rates of increase (In 2010, developing countries accounted for 69% of the total cases, while developed nations accounted for 20%) (1)

If you have prior heart events, then your clinician may want to consider GLP ones as part of like a comprehensive plan, right